|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4025 | |
| A61K 31/4178 | |||
| A61K 31/4453 | |||
| A61K 31/496 | |||
| A61K 31/5355 | |||
| A61K 45/06 | |||
| A61K 31/395 | |||
| A61P 27/02 |
| (11) | Number of the document | 2023918 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07795039.2 |
| Date of filing the European patent application | 2007-05-18 | |
| (97) | Date of publication of the European application | 2009-02-18 |
| (45) | Date of publication and mention of the grant of the patent | 2011-03-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/011919 |
| Date | 2007-05-18 |
| (87) | Number | WO 2007/136759 |
| Date | 2007-11-29 |
| (30) | Number | Date | Country code |
| 802208 P | 2006-05-19 | US |
| (72) |
HOUCK, David, Renwick, US
|
| (73) |
Scynexis, Inc.,
P.O. Box 12878, Research Triangle Park NC 27709-2878,
US
|
| (54) | CYCLOSPORINS FOR THE TREATMENT AND PREVENTION OF OCULAR DISORDERS |
| CYCLOSPORINS FOR THE TREATMENT AND PREVENTION OF OCULAR DISORDERS |